Can a Constipation Drug Clear Depression’s ‘Brain Fog’?

Published Date: 23 Jun 2026

A proof-of-concept study suggests the 5-HT4 receptor agonist prucalopride, which is approved for chronic constipation, improves cognition in patients with remitted depression.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

NIH research cuts leave cancer patient facing hard choice

4.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

5.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot